With a new gene therapy for age-related macular degeneration in clinical trials, Gregory S. Hageman, PhD, is ready to take on glaucoma. Age-related macular degeneration (AMD) and glaucoma are slowly ...

Web-based cataract vision simulation on PC screen Real-time simulation of glaucoma and cataracts aims to raise awareness in education and welfare sectors We created this simulator to bridge the gap ...

Macular degeneration and glaucoma can both lead to vision loss. However, macular degeneration tends to affect central vision while glaucoma affects side vision. The causes and treatment are also ...

Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide. The ...

Please provide your email address to receive an email when new articles are posted on . Individuals with glaucoma, AMD or cataract had an increased risk for both falls and fractures. These individuals ...

Sight-limiting eye disease can impact balance, posture, and gait even before patients become aware of visual impairments. Cataract, AMD, and glaucoma are each associated with increased risk for falls ...

National Eye Institute (NEI) researchers have mapped the organization of human retinal cell chromatin, the fibers that package three billion nucleotide-long DNA molecules into compact structures that ...

Optical coherence tomography (OCT) is a type of noninvasive imaging test. Ophthalmologists use OCT to create high-resolution, cross-sectional images of the inside of a person’s eye. OCT can help an ...

Patients using GLP-1 receptor agonists appear to have a lower risk of age-related macular degeneration and primary open-angle glaucoma. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) ...